Mastering the Art
of Vaccine Research
Our Commitment to Solutions
AMR’s stellar performance in vaccine trials has earned the company a reputation of excellence across the industry.
In 2020, during the global Coronavirus pandemic, one AMR clinical research center – AMR Kansas City – was selected as one of the two first centers in the nation to conduct a COVID-19 Investigational Vaccine Clinical Research Study. Since then, AMR has worked tirelessly to obtain COVID-19 studies including vaccinations, diagnosis and treatment.
AMR is a three-time recipient of the World Vaccine Congress’s Vaccine Industry Excellence (ViE) Award for “Best Clinical Trial Site or Network” (2013, 2015, 2017) and was a finalist for this prestigious award in 2016 and 2018.
Average Enrollment Goal Achieved
Average Retention Rate
Biopharma & Government Clients